Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003126
Filing Date
2025-03-17
Accepted
2025-03-17 16:28:00
Documents
136
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K chrs-20241231x10k.htm   iXBRL 10-K 4276802
2 EX-21.1 chrs-20241231xex21d1.htm EX-21.1 4193
3 EX-23.1 chrs-20241231xex23d1.htm EX-23.1 9313
4 EX-31.1 chrs-20241231xex31d1.htm EX-31.1 14880
5 EX-31.2 chrs-20241231xex31d2.htm EX-31.2 14222
6 EX-32.1 chrs-20241231xex32d1.htm EX-32.1 12384
7 GRAPHIC chrs-20241231x10k007.jpg GRAPHIC 58788
  Complete submission text file 0001558370-25-003126.txt   18567710

Data Files

Seq Description Document Type Size
8 EX-101.SCH chrs-20241231.xsd EX-101.SCH 127020
9 EX-101.CAL chrs-20241231_cal.xml EX-101.CAL 126848
10 EX-101.DEF chrs-20241231_def.xml EX-101.DEF 564899
11 EX-101.LAB chrs-20241231_lab.xml EX-101.LAB 1016275
12 EX-101.PRE chrs-20241231_pre.xml EX-101.PRE 879815
139 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20241231x10k_htm.xml XML 3464222
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36721 | Film No.: 25744888
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)